Frost & Sullivan Release: Who Will Benefit from Growth in the European NHL Therapeutics Market?

LONDON--(BUSINESS WIRE)--The Healthcare group at Frost & Sullivan (http://www.healthcare.frost.com/) is pleased to announce that it will be hosting an interactive analyst briefing on the European Non-Hodgkin’s Lymphoma Therapeutics Market on 29 May 2008 at 3pm BST (2pm GMT).
MORE ON THIS TOPIC